Skip to main content
Dementia and Geriatric Cognitive Disorders EXTRA logoLink to Dementia and Geriatric Cognitive Disorders EXTRA
. 2012 Apr 13;2(1):120–131. doi: 10.1159/000336224

Comparison of Four Verbal Memory Tests for the Diagnosis and Predictive Value of Mild Cognitive Impairment

Dina Silva a,*, Manuela Guerreiro a,b, João Maroco c, Isabel Santana d, Ana Rodrigues d, José Bravo Marques e, Alexandre de Mendonça a,f
PMCID: PMC3347876  PMID: 22590473

Abstract

Background

Mild cognitive impairment (MCI) is considered to be an early stage of a neurodegenerative disorder, particularly Alzheimer's disease, and the clinical diagnosis requires the objective demonstration of cognitive deficits. The aim of the present study was to evaluate the predictive value of MCI for the conversion to dementia when using four different verbal memory tests (Logical Memory, LM; California Verbal Learning Test, CVLT; Verbal Paired-Associate Learning, VPAL; and Digit Span, DS) in the MCI criteria.

Methods

Participants were consecutive patients with subjective cognitive complaints who performed a comprehensive neuropsychological evaluation and were not demented, observed in a memory clinic setting.

Results

At baseline, 272 non-demented patients reporting subjective cognitive complaints were included. During the follow-up time (3.0 ± 1.9 years), 58 patients converted to dementia and 214 did not. Statistically significant differences between the converters and non-converters were present in LM, VPAL, and CVLT. A multivariate Cox regression analysis combining the four memory tests revealed that only the CVLT test remained significant as a predictor of conversion to dementia. Non-demented patients with cognitive complaints diagnosed as having MCI according to abnormal (<1.5 SD) learning in the CVLT test had a 3.61 higher risk of becoming demented during the follow-up.

Conclusion

The verbal memory assessment using the CVLT should be preferred in the diagnostic criteria of MCI for a more accurate prediction of conversion to dementia.

Key Words: Mild cognitive impairment, Diagnostic criteria, Preclinical dementia, Alzheimer's disease, Memory impairment

Introduction

Many elderly people suffer from memory and other cognitive decline that is not severe enough to meet the criteria for dementia. These elderly people may be diagnosed as having mild cognitive impairment (MCI), implying a high risk of progression to dementia, usually Alzheimer's disease (AD), in the forthcoming years. In the initial formulation by Petersen et al. [1], MCI was based on (1) memory complaint, preferably corroborated by an informant; (2) memory impairment documented according to appropriate reference values; (3) essentially normal performance in non-memory cognitive domains; (4) generally preserved activities of daily living, and (5) absence of dementia. As repeatedly pointed out, several of these criteria would need operationalization. In particular, the test used to document the memory impairment and the cut-off score should be specified [2]. In spite of further refinements in the concept of MCI [3, 4, 5, 6, 7, 8, 9, 10], there is still no consensus about the specific memory test that should be used for the diagnosis of MCI or prodromal phase of AD [11, 12]. Thus, there is the need to compare systematically and prospectively the inclusion of different verbal memory tests in the MCI criteria, and to examine how this modifies the predictive value of the MCI diagnosis for conversion to dementia.

Deficits in episodic memory are associated with impaired encoding of the contextual information and consolidation of new verbal material [13, 14, 15], and a lower performance on tests of episodic verbal memory is a forerunner of future cognitive decline [16, 17, 18, 19]. A deficit in delayed recall assessment of episodic long-term memory, as opposed to the short-term or implicit memory assessment, would be particularly characteristic of initial AD [20], since it reflects involvement of the hippocampus and related medial temporal lobe structures. Significant verbal memory impairment, confirmed by neuropsychological testing, is considered the hallmark of both amnestic MCI and AD [4, 21]. So far, distinct tests of memory and learning have been used to establish the presence of memory impairment in order to fulfill the criteria for MCI, namely the Logical Memory (LM) test [19, 22, 23, 24], the Verbal Paired-Associate Learning (VPAL) test [23, 25], and the California Verbal Learning Test (CVLT) [17, 19, 26, 27, 28, 29, 30, 31].

The LM test [32] has been used for a long time to discriminate between healthy older adults and individuals with very mild dementia [33] and is still commonly used for the assessment of memory impairment in MCI patients nowadays. Recent studies associate the presence of impairment in LM with a higher rate of conversion to AD as compared with other episodic memory tests [24, 34]. Furthermore, the LM test was recently proposed as a screening tool for MCI in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study [35].

Previous studies showed that impairment in list learning tests might as well predict accurately the conversion to AD [17, 36]. Rabin et al. [19] showed that the impairment in the total learning score from the CVLT [37] had superior overall accuracy in distinguishing MCI from normal aging, even though that accuracy might be enhanced by the inclusion of the delayed recall condition of the LM test. The VPAL test was proposed to reveal the presence of memory deficits in MCI and AD patients, although the facilitation of the encoding process through the cued recall format could lead to a different memory deficit profile than in patients assessed with the CVLT [25].

Besides verbal memory impairment, some studies have evidenced that other memory domains are also altered in MCI, namely those related to working memory [13]. The Digit Span (DS) test measures auditory attention, immediate span of learning, and working memory. Impairment in the DS test was associated with future cognitive decline [38, 39]. However, it appears that working memory does not decline early in the neurodegenerative process of AD [40]. Therefore, the DS test was used in this study as a negative control to other applied tests that represent earlier markers of the neurodegenerative process observed in AD patients (e.g., tests assessing episodic memory and verbal learning). Another type of memory that evidenced more resistance to AD progression is semantic memory, since the lexical semantic system might be spared until the initial phase of dementia [41].

In the present study, non-demented patients with cognitive complaints who had a neuropsychological battery assessing different types of memory were followed prospectively. The aim was to determine whether the inclusion of four distinct memory tests, i.e., LM test, CVLT, VPAL test, and DS test, in the diagnostic criteria could modify the predictive value of MCI regarding conversion to dementia.

Methods

Research Participants

Participants were selected from the Cognitive Complaints Cohort [42], which is a prospective study conducted at the Institute of Molecular Medicine, Lisbon, to investigate the cognitive stability or evolution to dementia of subjects with cognitive complaints based on a comprehensive neuropsychological evaluation and other biomarkers. The study was approved by the local ethics committee.

Inclusion Criteria

The inclusion criteria were: (1) presence of cognitive complaints; (2) neuropsychological testing including all four memory tests compared in the present study, and (3) follow-up >6 months.

Exclusion Criteria

The exclusion criteria were: (1) presence of neurological or psychiatric disorders that may induce cognitive deficits; patients with major depression according to DSM-IV-TR [43] or serious depressive symptoms (indicated by a score on the Geriatric Depression Scale short version (GDS 15) of >10 points) were excluded; (2) systemic illness with cerebral impact; (3) history of alcohol abuse or recurrent substance abuse or dependence, and (4) presence of dementia according to DSM-IV-TR [43], or a Mini-Mental State Examination (MMSE) score below the cutoff for the Portuguese population, or significant impairment on activities of daily life according to the Blessed Dementia Rating Scale (BDRS) [44, 45].

Procedures

The baseline comprehensive neuropsychological assessment was carried out by the same team of trained neuropsychologists, supervised by M.G., following a standard protocol and comprising several tests and scales:

(1) MMSE [46, 47]: the MMSE is one of the most widely used brief instruments for the clinical evaluation of cognitive state in adults;

(2) Battery of Lisbon for the Assessment of Dementia(BLAD) [48]: the BLAD is a comprehensive neuropsychological battery evaluating multiple cognitive domains and validated for the Portuguese population [48]. Tests of interest for the present study were: LM(immediate and delayed recall; Wechsler Memory Scale, WMS); VPAL (immediate recall; WMS), and DS (forward and backward; WMS) [32];

(3) CVLT [27, 37]: the CVLT measures verbal learning assessing constructs as repetition learning, serial position effects, semantic organization, intrusion, and proactive interference. The word lists (list A and list B) are made up of 16 items from 4 different categories of ‘shopping list’ items. The trials of interest (trials with better discriminating ability for different stages of cognitive decline according to previous studies) [26] considered for the present study were: the total number of words from list A correctly recalled on the five learning trials (Atot) and long-delayed free recall (LDFR; number of words from list A correctly recalled after an interference period of 20 min);

(4) BDRS [44, 45]: the BDRS is a brief behavioral scale based on the interview of a close informant, assessing functional capacity for activities of daily living and changes in personality;

(5) Geriatric Depression Scale(GDS) [49, 50, 51]: the GDS is a self-report assessment used specifically to identify depression in the elderly. For this study, a short-form (15 items) of the self-report instrument was used.

Diagnosis of MCI

Diagnosis of MCI was based on criteria given by the MCI Working Group of the European Consortium on Alzheimer's disease [4]:

(1) Cognitive complaints coming from the patients or their families;

(2) The reporting of a decline in cognitive functioning relative to previous abilities during the past year by the patient or informant;

(3) Presence of cognitive impairment: in this study, four distinct memory tests to fulfill this diagnostic criterion were compared: LM, CVLT, VPAL, and DS; 3 cutoffs to define impairment were also analyzed (1, 1.5, and 2 SD below the mean);

(4) Absence of major repercussions on daily life (the patient may report difficulties concerning complex day-to-day activities).

Patients were assessed at follow-up for the presence of dementia and diagnosis of AD, according to the DSM-IV-TR [43] criteria.

Data Analysis

Demographic, clinical, and neuropsychological data were analyzed using the Mann-Whitney U test for numerical data and Pearson χ2 test for nominal data. All tests were two-tailed and a p value of <0.05 was assumed as statistically significant.

The neuropsychological assessment was standardized according to the age and education norms for the Portuguese population and z scores were calculated. The 1, 1.5, and 2.0 SD cutoffs below the mean were compared for establishing impairment on the memory tests.

Survival methods were chosen for analysis, since MCI conversion to dementia occurred at different times and the observations were censored. To explore the effect of impairment in different memory tests on the conversion to dementia during follow-up, univariate and multivariate Cox proportional hazards regression models were performed. For multivariate models, the Enter selection method was used to build the regression models. The memory tests were introduced as a binary variable (presence or not of impairment, coded as 0 and 1, respectively, and according to the cutoffs established, 1, 1.5, and 2.0 SD). Since converters to dementia were older at the baseline than non-converters, the multivariate model was adjusted for age. Survival time was calculated as the interval from the initial baseline evaluation to the diagnosis of dementia. For patients who remained non-demented, survival time was censored at the date of the last clinical assessment. A forest plot with the estimated hazard or risk of conversion to dementia for the different memory tests and cutoffs was displayed. Statistical analyses were performed using IBM SPSS Statistics 19 for Windows (2010 SPSS Inc., an IBM Company) and GraphPad Prism 5 for Windows (GraphPad Software, Inc., San Diego, Calif., USA) for graphical displays.

Results

At baseline, 272 patients reporting subjective cognitive complaints and not demented were included. During the follow-up time (3.0 ± 1.9 years), 58 patients (21%) converted to dementia, and 214 (79%) did not. Most cases that progressed to dementia were diagnosed as AD (85%). The presence of depressive symptoms and functional capacity did not differ between converters and non-converters (table 1). Likewise, the follow-up time was not significantly different between the two groups (table 1). The converters were older than the non-converters at the baseline assessment (table 1). Statistically significant differences between the converters and non-converters were present in all measures of verbal memory administrated with the exception of the DS test and a measure of forgetting from the CVLT (table 2). The analysis of other neuropsychological tests from the BLAD also showed significantly lower performances in converters as compared to non-converters, namely in measures of attention, initiative, and conceptual thinking; however, all scores were within 1 SD of the mean, showing that the converters had no major impairments in non-memory cognitive domains that would qualify them for a diagnosis of dementia (results not shown).

Table 1.

Baseline demographic and clinic characterization data

Converters (n = 58) Non-converters (n = 214) p value
Age, years 69.9 ± 8.7 66.2 ± 9.3 0.004#,*
Gender (female/male) 38/20 122/92 0.293
Formal education, years 9.3 ± 5.1 10.1 ± 4.8 0.221#
Follow-up time, years 2.8 ± 1.7 3.1 ± 1.9 0.427#
GDS 4.8 ± 3.7 4.8 ± 4.1 0.831#
BDRS 3.4 ± 2.5 2.9 ± 1.9 0.450#
MMSE 25.4 ± 2.5 28.3 ± 1.9 0.001#,*

Data are number of patients or mean ± SD.

#

Mann-Whitney test.

Pearson χ2 test.

*

Statistically significant (p < 0.05).

Table 2.

Verbal memory tests at baseline

Converters (n = 58) Non-converters (n = 214) p value#
LM Immediate recall −1.46 ± 1.09 −0.89 ± 1.00 <0.001*
Delayed recall − 1.61 ± 1.11 − 0.84 ± 1.08 <0.001*
Forgetting index − 0.38 ± 0.47 − 0.11 ± 0.45 0.001*
VPAL −1.48 ± 1.14 −0.74 ± 1.15 <0.001*
CVLT Five learning trials total −3.22 ± 1.45 −1.81 ± 1.44 <0.001*
Long delayed recall − 3.30 ± 1.77 − 1.64 ± 1.61 <0.001*
Forgetting index − 0.11 ± 0.65 0.06 ± 0.44 0.142
DS Forward 0.40 ± 1.63 0.41 ± 1.27 0.837
Backwards 0.05 ± 1.30 0.30 ± 1.15 0.084

Data are mean ± SD.

Means of Z scores, calculated according to the equation [z = (x − mean)/SD].

#

Mann-Whitney test.

*

Statistically significant (p < 0.05).

Of the 272 patients reporting subjective cognitive complaints and not demented, 33 (12%) had no alterations at the baseline in the memory tests selected for the present study (considering the cutoff <1.5 SD), 72 (26%) had deficits at only 1 of the memory tests, 167 (62%) showed deficits in ≥2 memory tests (from those, 4 (2%) had deficits in at least 1 measure of all memory tests). The number of patients diagnosed as having MCI based on each specific memory test and 3 different cutoff values is shown in table 3. The CVLT test was the verbal memory test that categorized more individuals as MCI across the 3 cutoffs (table 3).

Table 3.

Number of subjects diagnosed as MCI according to distinct measures and cutoffs of memory tests

1 SD 1.5 SD 2 SD
LM, n (%) Immediate recall 152 (55.9) 106 (39) 47 (17.3)
Delayed recall 137 (50.4) 98 (36) 55 (20.2)
CVLT, n (%) Five learning trials total 195 (71.7) 166 (61) 123 (45.2)
Long delayed recall 147 (54) 117 (43) 91 (33.5)
VPAL, n (%) 132 (48.5) 86 (31.6) 47 (17.3)
DS, n (%) Forward 31 (11.4) 24 (8.8) 3 (1.1)
Backward 36 (13.2) 14 (5.1) 9 (3.3)

Since the conversion to dementia occurred during the follow-up time at different moments, a survival analysis was performed. The diagnosis of MCI on the basis of an abnormal value for each of the memory tests, LM, CVLT, and VPAL, according to the cutoffs determined for impairment, carried a significant risk of conversion to dementia during the follow-up (univariate Cox regression model fitted to the results of each memory test; fig. 1). The diagnosis of MCI on the basis of an abnormal value for the DS backward condition (all cutoffs) and forward condition (1 and 2 SD cutoffs) was not significantly associated with the risk of conversion to dementia during the follow-up (fig. 1). The three significant memory tests showed overlapping hazard risks for conversion to dementia (fig. 1).

Fig. 1.

Fig. 1

Verbal memory tests and risk of progression to dementia (hazard ratios and confidence intervals from univariate Cox regression analysis).

To test whether the verbal memory tests used in the diagnostic criteria of MCI (LM, CVLT, and VPAL) that individually had shown to accurately predict future conversion to dementia, could be combined to improve their predictive value, a multivariate Cox regression analysis was performed. In an attempt to increase the power of multivariate analysis, we reduced the number of measures in the study and selected two at maximum for each memory test. The measures not selected for the present study also showed overlapping hazard risks and did not add any further accuracy for predicting future conversion to dementia. In the multivariate Cox regression analysis only the CVLT (learning measure for the cutoff <1.5 SD and long delayed recall for the other cutoffs) remained significant as a predictor of conversion to dementia (table 4). Non-demented patients with cognitive complaints diagnosed with MCI according to abnormal (cutoff commonly used of <1.5 SD) learning in the CVLT had a 3.61 higher risk of becoming demented in the follow-up as compared to those who had normal learning in the CVLT (table 4).

Table 4.

Verbal memory tests and risk of progression to dementia (multivariate Cox regression analysis)

B SE Exp (B) 95 % CI for Exp (B) Wald statistic p
−1 SD
Logical Memory test Immediate recall 0.03 0.54 1.04 0.36−2.97 0.004 0.95
Delayed recall 0.71 0.50 2.04 0.77−5.44 2.04 0.15
California Verbal Five learning trials 1.24 0.78 3.45 0.75−15.91 2.52 0.11
Learning test Long delayed recall 1.30 0.57 3.65 1.20−11.09 5.22 0.02*
Verbal Paired Associate
Learning test 0.25 0.35 1.29 0.65−2.55 0.53 0.47
Digit Span test Forward 0.29 0.53 1.34 0.47−3.78 0.30 0.58
Backwards 0.31 0.47 1.37 0.55−3.43 0.45 0.50
−1.5 SD
Logical Memory test Immediate recall 0.03 0.43 1.03 0.44−2.41 0.004 0.95
Delayed recall 0.52 0.45 1.68 0.69−4.06 1.31 0.25
California Verbal Five learning trials 1.28 0.57 3.61 1.19−10.99 5.12 0.02*
Learning test Long delayed recall 0.76 0.49 2.13 0.81−5.60 2.37 0.12
Verbal Paired Associate
Learning test 0.55 0.38 1.73 0.83−3.61 2.12 0.15
Digit Span test Forward 0.92 0.53 2.51 0.89−7.06 3.04 0.08
Backwards 0.60 0.75 1.82 0.42−7.97 0.64 0.43
−2 SD
Logical Memory test Immediate recall 0.64 0.43 1.89 0.82−4.37 2.21 0.14
Delayed recall 0.43 0.43 1.53 0.66−3.58 0.96 0.33
California Verbal Five learning trials 0.79 0.55 2.21 0.75−6.54 2.07 0.15
Learning test Long delayed recall 1.45 0.59 4.26 1.35−13.43 6.11 0.01*
Verbal Paired Associate
Learning test 0.28 0.43 1.32 0.57−3.05 0.41 0.52
Digit Span test Forward −8.63 408.64 <0.001 0.00−n.d. <0.001 0.98
Backwards − 0.07 1.03 0.94 0.12−7.11 0.004 0.95
*

Statistically significant (p < 0.05).

Discussion

The present study shows that different verbal memory tests, LM, CVLT, and VPAL, when used in non-demented patients with cognitive complaints to establish memory impairment in the diagnosis of MCI, are not significantly different to predict the progression to dementia. However, the MCI criteria using the CVLT had the highest predictive value, which was not improved by adding other memory tests.

Although it has been argued that the use of a memory test battery offers a better sensitivity to the earlier diagnosis of MCI [52], we showed that only the CVLT remains significant on the multivariate Cox regression model as a predictor of progression to dementia, and other memory tests did not significantly add to the predictive value. The assessment of verbal memory based on list learning was found to be predictive of future conversion to dementia in earlier phases, possibly due to the reduced use of learning strategies [53]. Previous studies have also suggested that list learning represents a more demanding encoding test than story recall, is more sensitive to executive dysfunction, and offers a better prediction of conversion to dementia [19, 54, 55]. The higher frequency of impaired performance for CVLT at baseline highlights the demanding character of the task, indicating that it might be an early marker for cognitive decline [17].

Different measures of verbal memory tests used for the diagnosis of MCI may assess different stages of the neurodegenerative process by relying on distinct cognitive resources, so the contribution to diagnostic accuracy and predictive value is unique [14]. Both measures of immediate and delayed free recall were analyzed, because there is some evidence that long-term memory is more extensively impaired in MCI patients than short-term memory and, more importantly, has evidenced a greater sensitivity for the identification of amnestic MCI which will progress to dementia [20]. Verbal memory impairment can possibly correspond to either a defective consolidation of information relying on an alteration of mesiotemporal areas, or to a difficulty in elaborative encoding and afterwards correct retrieval of information, which in this case is associated with an alteration of frontal areas. MCI patients at risk of conversion to AD are expected to present deficits in learning (encoding and storage) rather than in the retrieval process [56, 57]. Some verbal memory tests assess primarily the capacity of storage, and for that aim semantic cues are systematically provided during the encoding phase in order to facilitate the retrieval process. For instance, the Free and Cued Selective Reminding Test [58] assesses specifically the storage capacity of MCI patients with focus on the amnestic syndrome of the medial temporal type associated with a future progression to dementia [52, 53]. According to a recent review, the studies that determined the predictive value of this test for future conversion to dementia also evidenced that delayed recall measures were less sensitive and specific than immediate recall measures, supporting the hypothesis of a failure at the initial learning process (although providing semantic cues), instead of forgetting due to inadequate storage of the information [57]. Other studies have shown that MCI patients at risk of conversion to dementia (namely AD) could benefit from semantic cues on the encoding phase in a similar way as normal controls, suggesting that the deficits in encoding correctly the information during the learning process, and not a difficulty in the storage process itself, would lead to retrieval impairment [27, 57, 61].

Bearing in mind the above mentioned, we decided to examine the CVLT performance for the total learning and delayed recall, which are also the measures associated with a better discrimination between normal aging, MCI, and AD [26]. Verbal learning tests were analyzed on associative (VPAL) and non-associative (CVLT) conditions in order to assess different stages of impairment progression. Deficits in associative learning tests are present in a more advanced stage of progression in MCI [62] and, therefore, may not be the best predictors for conversion at earlier phases. Interestingly, the use of different cutoffs for CVLT impairment did not considerably modify the risk of progression to dementia.

The present results suggest that a measure of working memory, like the DS backward, should not be used to qualify for memory impairment in the MCI diagnostic criteria, and the prediction of future conversion to dementia would be unreliable. Working memory and visuospatial ability have been proposed as functions that decline slowly in MCI patients [63]. A recent study showed that subjects presenting subjective cognitive complaints and impairment in DS might have a higher risk of future conversion to MCI but did not compare the DS predictive value to other memory tests [38].

One limitation of the present study is the focus on a restricted number of verbal memory tests commonly used in clinical practice to evaluate memory in non-demented patients with suspected cognitive decline. Clearly, it would be interesting to evaluate other memory modalities, with visual or semantic memory tests. Nevertheless, several studies showed that their diagnostic value in the identification of MCI patients at risk of conversion to dementia do not clearly overtake that of verbal episodic memory tests [18, 64, 65, 66]. Another limitation of the present study was that it focused on neuropsychological data, and other biomarkers were not considered. Recently, many studies have been published combining different biomarkers in non-demented subjects with cognitive complaints for predicting future conversion to dementia. Consequently, the choice of specific verbal memory tests in the neuropsychological assessment, in conjunction with other biomarkers, may be crucial to accurately predict future conversion to dementia.

In conclusion, different memory tests, namely LM, CVLT, and VPAL, can be used to establish the diagnosis of MCI and predict the progression to dementia. Considering our results, the MCI criteria using the CVLT had the highest predictive value, which was not improved by adding other memory tests, and taking into account that there are frequent limitations in clinical practice to apply an extensive neuropsychological battery to all individuals with suspected cognitive decline [67], we propose that a list learning task could be the preferred test to establish memory impairment in MCI diagnosis.

Disclosure Statement

The authors of this paper do not have any commercial associations that might pose a conflict of interest in connection with the manuscript.

Acknowledgements

Supported by grants from Fundação Calouste Gulbenkian and Fundação para a Ciência e Tecnologia. The authors acknowledge the facilities provided by Memoclínica.

References

  • 1.Petersen R, Smith G, Waring S, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. doi: 10.1001/archneur.56.3.303. [DOI] [PubMed] [Google Scholar]
  • 2.Petersen RC. Challenges of epidemiological studies of mild cognitive impairment. Alzheimer Dis Assoc Disord. 2004;18:1–2. doi: 10.1097/00002093-200401000-00001. [DOI] [PubMed] [Google Scholar]
  • 3.Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246. doi: 10.1111/j.1365-2796.2004.01380.x. [DOI] [PubMed] [Google Scholar]
  • 4.Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J, MCI Working Group of the European Consortium on Alzheimer's Disease (EADC) Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry. 2006;77:714–718. doi: 10.1136/jnnp.2005.085332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chertkow H, Nasreddine Z, Joanette Y, Drolet V, Kirk J, Massoud F, Belleville S, Bergman H. Mild cognitive impairment and cognitive impairment, no dementia: part A, concept and diagnosis. Alzheimers Dement. 2007;3:266–282. doi: 10.1016/j.jalz.2007.07.013. [DOI] [PubMed] [Google Scholar]
  • 6.Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C, Medical Research Council Cognitive Function and Ageing Study Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc. 2008;56:1424–1433. doi: 10.1111/j.1532-5415.2008.01820.x. [DOI] [PubMed] [Google Scholar]
  • 7.Visser PJ, Verhey FRJ. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. Psychol Med. 2008;38:113–122. doi: 10.1017/S0033291707000554. [DOI] [PubMed] [Google Scholar]
  • 8.Saxton J, Snitz BE, Lopez OL, Ives DG, Dunn LO, Fitzpatrick A, Carlson MC, Dekosky ST, GEM Study Investigators Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry. 2009;80:737–743. doi: 10.1136/jnnp.2008.160705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009;17:368–375. doi: 10.1097/JGP.0b013e31819431d5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR., Jr Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447–1455. doi: 10.1001/archneurol.2009.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement. 2011;7:270–279. doi: 10.1016/j.jalz.2011.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol. 2004;3:246–248. doi: 10.1016/S1474-4422(04)00710-0. [DOI] [PubMed] [Google Scholar]
  • 13.Belleville S, Sylvain-Roy S, de Boysson C, Ménard MC. Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res. 2008;169:365–375. doi: 10.1016/S0079-6123(07)00023-4. [DOI] [PubMed] [Google Scholar]
  • 14.Moulin CJ, James N, Freeman JE, Jones RW. Deficient acquisition and consolidation: intertrial free recall performance in Alzheimer's disease and mild cognitive impairment. J Clin Exp Neuropsychol. 2004;26:1–10. doi: 10.1076/jcen.26.1.1.23940. [DOI] [PubMed] [Google Scholar]
  • 15.Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res. 2002;924:113–115. doi: 10.1016/s0006-8993(01)03200-0. [DOI] [PubMed] [Google Scholar]
  • 16.Almkvist O, Basun H, Bäckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B. Mild cognitive impairment-an early stage of Alzheimer's disease? J Neural Transm Suppl. 1998;54:21–29. doi: 10.1007/978-3-7091-7508-8_3. [DOI] [PubMed] [Google Scholar]
  • 17.Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol. 2007;64:862–871. doi: 10.1001/archneur.64.6.862. [DOI] [PubMed] [Google Scholar]
  • 18.Guarch J, Marcos T, Salamero M, Gastó C, Blesa R. Mild cognitive impairment: a risk indicator of later dementia, or a preclinical phase of the disease? Int J Geriatr Psychiatry. 2008;23:257–265. doi: 10.1002/gps.1871. [DOI] [PubMed] [Google Scholar]
  • 19.Rabin LA, Paré N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB. Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Aging Neuropsychol Cogn. 2009;16:357–376. doi: 10.1080/13825580902825220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Perri R, Serra L, Carlesimo GA, Caltagirone C, Early Diagnosis Group of the Italian Interdisciplinary Network on Alzheimer's Disease Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease. Neuropsychology. 2007;21:549–558. doi: 10.1037/0894-4105.21.5.549. [DOI] [PubMed] [Google Scholar]
  • 21.Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–746. doi: 10.1016/S1474-4422(07)70178-3. [DOI] [PubMed] [Google Scholar]
  • 22.Cunje A, Molloy DW, Standish TI, Lewis DL. Alternate forms of logical memory and verbal fluency tasks for repeated testing in early cognitive changes. Int Psychogeriatr. 2007;19:65–75. doi: 10.1017/S1041610206003425. [DOI] [PubMed] [Google Scholar]
  • 23.Brooks BL, Iverson GL, Holdnack JA, Feldman HH. Potential for misclassification of mild cognitive impairment: a study of memory scores on the Wechsler Memory Scale-III in healthy older adults. J Int Neuropsychol Soc. 2008;14:463–478. doi: 10.1017/S1355617708080521. [DOI] [PubMed] [Google Scholar]
  • 24.Guo Q, Zhao Q, Chen M, Ding D, Hong Z. A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord. 2009;23:253–259. doi: 10.1097/WAD.0b013e3181999e92. [DOI] [PubMed] [Google Scholar]
  • 25.Pike KE, Rowe CC, Moss SA, Savage G. Memory profiling with paired associate learning in Alzheimer's disease, mild cognitive impairment, and healthy aging. Neuropsychology. 2008;22:718–728. doi: 10.1037/a0013050. [DOI] [PubMed] [Google Scholar]
  • 26.Greenaway MC, Lacritz LH, Binegar D, Weiner MF, Lipton A, Munro Cullum C. Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging. Cogn Behav Neurol. 2006;19:79–84. doi: 10.1097/01.wnn.0000208290.57370.a3. [DOI] [PubMed] [Google Scholar]
  • 27.Ribeiro F, Guerreiro M, de Mendonça A. Verbal learning and memory deficits in Mild Cognitive Impairment. J Clin Exp Neuropsychol. 2007;29:187–197. doi: 10.1080/13803390600629775. [DOI] [PubMed] [Google Scholar]
  • 28.Wehling E, Lundervold AJ, Standnes B, Gjerstad L, Reinvang I. APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits. Behav Brain Funct. 2007;3:57. doi: 10.1186/1744-9081-3-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bläsi S, Zehnder AE, Berres M, Taylor KI, Spiegel R, Monsch AU. Norms for change in episodic memory as a prerequisite for the diagnosis of mild cognitive impairment (MCI) Neuropsychology. 2009;23:189–200. doi: 10.1037/a0014079. [DOI] [PubMed] [Google Scholar]
  • 30.Teng E, Tingus KD, Lu PH, Cummings JL. Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;28:168–178. doi: 10.1159/000235732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Riepe MW, Karl J, Tumani H, von Arnim CA. Tau-proteins as gender-specific state markers in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30:93–100. doi: 10.1159/000318738. [DOI] [PubMed] [Google Scholar]
  • 32.Wechsler D. Wechsler Memory Scale. ed 3 (WMS-III) San Antonio, TX: Harcourt Assessment; 1945/1997. [Google Scholar]
  • 33.Storandt M, Hill RD. Very mild senile dementia of the Alzheimer's type: II. Psychometric test performance. Arch Neurology. 1989;46:383–386. doi: 10.1001/archneur.1989.00520400037017. [DOI] [PubMed] [Google Scholar]
  • 34.Baek MJ, Kim HJ, Ryu HJ, Lee SH, Han SH, Na HR, Chang Y, Chey JY, Kim S. The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011;18:214–229. doi: 10.1080/13825585.2010.530221. [DOI] [PubMed] [Google Scholar]
  • 35.Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010;6:239–246. doi: 10.1016/j.jalz.2010.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Maruff P, Collie A, Darby D, Weaver-Cargin J, Masters C, Currie J. Subtle memory decline over 12 months in mild cognitive impairment. Dement Geriatr Cogn Disord. 2004;18:342–348. doi: 10.1159/000080229. [DOI] [PubMed] [Google Scholar]
  • 37.Delis DC, Kramer JH, Kaplan E, Ober BA. The California Verbal Learning Test: Research Edition Adult Version. San Antonio: The Psychological Corporation; 1987. [Google Scholar]
  • 38.Kurt P, Yener G, Oguz M. Impaired digit span can predict further cognitive decline in older people with subjective memory complaint: a preliminary result. Aging Ment Health. 2011;15:364–369. doi: 10.1080/13607863.2010.536133. [DOI] [PubMed] [Google Scholar]
  • 39.Wilson RS, Leurgans SE, Boyle PA, Bennett DA. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011;68:351–356. doi: 10.1001/archneurol.2011.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wiechmann A, Hall JR, O'Bryant SE. The utility of the spatial span in a clinical geriatric population. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011;18:56–63. doi: 10.1080/13825585.2010.510556. [DOI] [PubMed] [Google Scholar]
  • 41.Balthazar ML, Martinelli JE, Cendes F, Damasceno BP. Lexical semantic memory in amnestic mild cognitive impairment and mild Alzheimer's disease. Arq Neuropsiquiatr. 2007;65:619–622. doi: 10.1590/s0004-282x2007000400014. [DOI] [PubMed] [Google Scholar]
  • 42.Maroco J, Silva D, Rodrigues A, Guerreiro M, Santana I, de Mendonça A. Data mining methods in the prediction of dementia: a real-data comparison of the accuracy, sensitivity and specificity of linear discriminant analysis, logistic regression, neural networks, support vector machines, classification trees and random forests. BMC Res Notes. 2011;4:299. doi: 10.1186/1756-0500-4-299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.American Psychiatric Association . DSM-IV-TR. ed 4, text revision. Washington, DC: APA; 2000. [Google Scholar]
  • 44.Blessed G, Tomlinson B, Roth M. Association between quantitative measures of dementing and senile change in cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  • 45.Garcia C. Blessed Dementia Rating Scale (BDRS) In: de Mendonça A, Guerreiro M, editors. Escalas e Testes na Demência. ed 3. Lisboa: Grupo de Estudos de Envelhecimento Cerebral e Demência; 2008. pp. 105–106. [Google Scholar]
  • 46.Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  • 47.Guerreiro M: Contributo da Neuropsicologia para o Estudo das Demências. Dissertação de Doutoramento em Ciências Biomédicas, Faculdade de Medicina de Lisboa, 1998, pp 13–15, 37–61.
  • 48.Garcia C: Doença de Alzheimer, problemas do diagnóstico clínico. Tese de Doutoramento. Faculdade de Medicina de Lisboa, 1984.
  • 49.Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37–49. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]
  • 50.Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical Gerontology: A Guide to Assessment and Intervention. New York: Haworth; 1986. pp. 165–173. [Google Scholar]
  • 51.Barreto J, Leuschner A, Santos F, Sobral M. Geriatric Depression Scale (GDS) In: de Mendonça A, Guerreiro M, editors. Escalas e Testes na Demência. ed 3. Lisboa: Grupo de Estudos de Envelhecimento Cerebral e Demência; 2008. pp. 71–72. [Google Scholar]
  • 52.de Jager CA, Budge MM. Stability and predictability of the classification of mild cognitive impairment as assessed by episodic memory test performance over time. Neurocase. 2005;11:72–79. doi: 10.1080/13554790490896820. [DOI] [PubMed] [Google Scholar]
  • 53.Schrijnemaekers AM, de Jager CA, Hogervorst E, Budge MM. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. J Clin Exp Neuropsychol. 2006;28:438–455. doi: 10.1080/13803390590935462. [DOI] [PubMed] [Google Scholar]
  • 54.Tremont G, Halpert S, Javorsky DJ, Stern RA. Differential impact of executive dysfunction on verbal list learning and story recall. Clin Neuropsychol. 2000;14:295–302. doi: 10.1076/1385-4046(200008)14:3;1-P;FT295. [DOI] [PubMed] [Google Scholar]
  • 55.Tremont G, Miele A, Smith MM, Westervelt HJ. Comparison of verbal memory impairment rates in mild cognitive impairment. J Clin Exp Neuropsychol. 2010;32:630–636. doi: 10.1080/13803390903401328. [DOI] [PubMed] [Google Scholar]
  • 56.Traykov L, Rigaud AS, Cesaro P, Boller F. Neuropsychological impairment in the early Alzheimer's disease. Encephale. 2007;33:310–316. doi: 10.1016/s0013-7006(07)92044-8. [DOI] [PubMed] [Google Scholar]
  • 57.Carlesimo GA, Perri R, Caltagirone C. Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: a review of the evidence. Neuropsychol Rev. 2011;21:54–65. doi: 10.1007/s11065-010-9153-7. [DOI] [PubMed] [Google Scholar]
  • 58.Buschke H. Cued-recall in amnesia. J Clin Neuropsychol. 1984;6:433–440. doi: 10.1080/01688638408401233. [DOI] [PubMed] [Google Scholar]
  • 59.Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology. 2007;69:1859–1867. doi: 10.1212/01.wnl.0000279336.36610.f7. [DOI] [PubMed] [Google Scholar]
  • 60.Auriacombe S, Helmer C, Amieva H, Berr C, Dubois B, Dartigues JF. Validity of the free and cued selective reminding test in predicting dementia: The 3C study. Neurology. 2010;74:1760–1767. doi: 10.1212/WNL.0b013e3181df0959. [DOI] [PubMed] [Google Scholar]
  • 61.Perri R, Carlesimo GA, Serra L, Caltagirone C, Early Diagnosis Group of the Italian Interdisciplinary Network on Alzheimer's Disease Characterization of memory profile in subjects with amnestic mild cognitive impairment. J Clin Exp Neuropsychol. 2005;27:1033–1055. doi: 10.1080/13803390490919317. [DOI] [PubMed] [Google Scholar]
  • 62.Egerházi A, Berecz R, Bartók E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:746–751. doi: 10.1016/j.pnpbp.2007.01.011. [DOI] [PubMed] [Google Scholar]
  • 63.Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205. doi: 10.1212/wnl.59.2.198. [DOI] [PubMed] [Google Scholar]
  • 64.Alescio-Lautier B, Michel BF, Herrera C, Elahmadi A, Chambon C, Touzet C, Paban V. Visual and visuospatial short-term memory in mild cognitive impairment and Alzheimer disease: role of attention. Neuropsychologia. 2007;45:1948–1960. doi: 10.1016/j.neuropsychologia.2006.04.033. [DOI] [PubMed] [Google Scholar]
  • 65.Ahmed S, Mitchell J, Arnold R, Nestor PJ, Hodges JR. Predicting rapid clinical progression in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2008;25:170–177. doi: 10.1159/000113014. [DOI] [PubMed] [Google Scholar]
  • 66.Gigi A, Babai R, Penker A, Hendler T, Korczyn AD. Prefrontal compensatory mechanism may enable normal semantic memory performance in mild cognitive impairment (MCI) J Neuroimaging. 2010;20:163–168. doi: 10.1111/j.1552-6569.2009.00386.x. [DOI] [PubMed] [Google Scholar]
  • 67.Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Ann Med. 2000;32:6–14. doi: 10.3109/07853890008995904. [DOI] [PubMed] [Google Scholar]

Articles from Dementia and Geriatric Cognitive Disorders EXTRA are provided here courtesy of Karger Publishers

RESOURCES